Insider Selling: Privia Health Group (NASDAQ:PRVA) CFO Sells 6,391 Shares of Stock
Privia Health Group's (NASDAQ:PRVA) CFO, David Mountcastle, sold 6,391 shares of company stock for over $141,305 on March 16th, adding to several sales since late February. This transaction reduced his stake by 2.82%, contributing to a 2.3% share price dip to $21.59. Despite the insider selling, analysts maintain a "Moderate Buy" rating with an average $31 price target, reflecting strong recent earnings that surpassed expectations.
MAR 18·MarketBeat→
Insider Selling: Privia Health Group (NASDAQ:PRVA) CEO Sells 26,509 Shares of Stock
Privia Health Group (NASDAQ:PRVA) CEO Parth Mehrotra recently sold 26,509 shares of the company's stock for over $586,000, part of a larger sale of 165,037 shares totaling approximately $3.69 million between March 6th and 16th. These sales reduced his ownership by 4.56%. Despite the insider selling and a 2.3% dip in stock price post-filings, Privia Health Group recently exceeded quarterly earnings estimates, and analysts maintain a "Moderate Buy" rating with an average price target of $31.
MAR 17·MarketBeat→
Privia Health Group, Inc. $PRVA Position Lessened by Cinctive Capital Management LP
Cinctive Capital Management LP significantly reduced its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 92.5% in the third quarter. This move comes as institutional ownership remains high at 94.48%, despite recent insider selling by the CEO and CFO. Analysts maintain a "Moderate Buy" rating with a consensus target price of $31.00, following Privia Health's beat on Q3 EPS and revenue estimates.
